From the Journals

Anti-CD146 Linked to Silica in Systemic Sclerosis

Comparative analysis across exposed workers, cancer controls, and healthy donors supports specificity.

Share

This study explores the association of anti-CD146 autoantibodies with systemic sclerosis, highlighting their correlation with occupational exposure, particularly to crystalline silica. It examined 93 systemic sclerosis patients, revealing a 15% positivity rate for anti-CD146 antibodies, compared to 5% in healthy controls. Notably, this antibody showcases 57% sensitivity and 88% specificity for indicating occupational exposure. The findings suggest that AACD146 may serve as a significant biomarker in diagnosing and managing systemic sclerosis related to occupational factors, despite limitations in study design.

Original Source(s)

Anti-CD146 Linked to Silica in Systemic Sclerosis

Comparative analysis across exposed workers, cancer controls, and healthy donors supports specificity.

  • by Kathryn Wighton

  • March 5, 2026

  • 3 min

Related Content

Drooling Flags Severe Dermatomyositis

Three cases suggest drooling may mark advanced dermatomyositis with dysphagia, aspiration pneumonia, and poor response to treatment.

A Look Ahead at Rheumatology in 2024

A rheumatologist reflected on rheumatology developments in 2023 and looked ahead to the developments and challenges the field may face in 2024.

Potential New Lyme Disease Therapy Advances to Human Safety Trials

The novel antibiotic therapy hygromycin A has advanced to human safety trials to determine its potential as a future treatment for Lyme disease.